{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:54:44Z","timestamp":1778288084260,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vasopressin is a second-line vasoactive agent for refractory septic shock. Vasopressin loading is not generally performed because of the lack of evidence for its effects and safety. However, based on our previous findings, we hypothesized it can predict the responsibility to vasopressin infusion with safety, and prospectively examined it in the present study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Vasopressin loading was performed via the intravenous administration of a bolus of 1 U, followed by its continuous infusion at 1U\/h in patients with septic shock treated with\u2009\u2265\u20090.2\u00a0\u03bcg\/kg\/min noradrenaline. An arterial pressure wave analysis was conducted, and endocrinological tests were performed immediately prior to vasopressin loading. We classified patients into responders\/non-responders based on mean arterial pressure (MAP) changes after vasopressin loading. Based on our previous findings, the lower tertile of MAP changes was selected as the cut-off. The change in the catecholamine index (CAI) after 6\u00a0h was assigned as the primary outcome. Digital ischemia, mesenteric ischemia, and myocardial ischemia during the admission period were prospectively and systematically recorded as adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ninety-two patients were registered during the study period and examined. Sixty-two patients with a MAP change\u2009&gt;\u200922\u00a0mmHg were assigned as responders and the others as non-responders. Blood adrenocorticotropic hormone levels were significantly higher in non-responders. Stroke volume variations were higher in responders before loading, while stroke volume and dP\/dt<jats:sub>max<\/jats:sub> were higher in responders after loading. Median CAI changes were \u2212\u00a010 in responders and 0 in non-responders, which was significantly lower in the former (p\u2009&lt;\u20090.0001). AUROC of MAP change with vasopressin loading to predict CAI change\u2009&lt;\u20090 after continuous infusion was 0.843 with sensitivity of 0.92 and specificity of 0.77. Ischemia events were observed in 5 cases (5.4%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Vasopressin loading may be safely introduced for septic shock. Vasopressin loading may be used to predict responses to its continuous infusion and select appropriate strategies to increase blood pressure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-023-04583-7","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T14:01:33Z","timestamp":1689948093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Vasopressin Loading for Refractory septic shock (VALOR) study: a prospective observational study"],"prefix":"10.1186","volume":"27","author":[{"given":"Kensuke","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ikechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineji","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"3","key":"4583_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","volume":"96","author":"BM Patel","year":"2002","unstructured":"Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96(3):576\u201382. https:\/\/doi.org\/10.1097\/00000542-200203000-00011.","journal-title":"Anesthesiology"},{"issue":"11","key":"4583_CR2","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","volume":"32","author":"F Lauzier","year":"2006","unstructured":"Lauzier F, L\u00e9vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32(11):1782\u20139. https:\/\/doi.org\/10.1007\/s00134-006-0378-0.","journal-title":"Intensive Care Med"},{"issue":"9","key":"4583_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877\u201387. https:\/\/doi.org\/10.1056\/NEJMoa067373.","journal-title":"N Engl J Med"},{"issue":"5","key":"4583_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA. 2016;316(5):509\u201318. https:\/\/doi.org\/10.1001\/jama.2016.10485.","journal-title":"JAMA"},{"issue":"7","key":"4583_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF01694349","volume":"18","author":"MA Hayes","year":"1992","unstructured":"Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med. 1992;18(7):433\u20136. https:\/\/doi.org\/10.1007\/BF01694349.","journal-title":"Intensive Care Med"},{"issue":"5","key":"4583_CR6","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","volume":"31","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser MW, Mayr AJ, T\u00fcr A, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med. 2003;31(5):1394\u20138. https:\/\/doi.org\/10.1097\/01.CCM.0000059722.94182.79.","journal-title":"Crit Care Med"},{"issue":"6","key":"4583_CR7","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1378\/chest.124.6.2256","volume":"124","author":"FM van Haren","year":"2003","unstructured":"van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest. 2003;124(6):2256\u201360. https:\/\/doi.org\/10.1378\/chest.124.6.2256.","journal-title":"Chest"},{"issue":"11","key":"4583_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"key":"4583_CR9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1172\/JCI105038","volume":"43","author":"JW Czaczkes","year":"1964","unstructured":"Czaczkes JW, Kleeman CR, Koenig M. Physiologic studies of antidiuretic hormone by its direct measurement in human plasma. J Clin Invest. 1964;43:1625\u201340. https:\/\/doi.org\/10.1172\/JCI105038.","journal-title":"J Clin Invest"},{"issue":"4","key":"4583_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00005344-198007000-00004","volume":"2","author":"J M\u00f6hring","year":"1980","unstructured":"M\u00f6hring J, Gl\u00e4nzer K, Maciel JA, et al. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol. 1980;2(4):367\u201376. https:\/\/doi.org\/10.1097\/00005344-198007000-00004.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"4583_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","volume":"37","author":"JA Russell","year":"2009","unstructured":"Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009;37(3):811\u20138. https:\/\/doi.org\/10.1097\/CCM.0b013e3181961ace.","journal-title":"Crit Care Med"},{"key":"4583_CR12","doi-asserted-by":"publisher","first-page":"644195","DOI":"10.3389\/fmed.2021.644195","volume":"8","author":"K Nakamura","year":"2021","unstructured":"Nakamura K, Nakano H, Naraba H, et al. Vasopressin Loading for Refractory septic shock: a preliminary analysis of a case series. Front Med (Lausanne). 2021;8:644195. https:\/\/doi.org\/10.3389\/fmed.2021.644195.","journal-title":"Front Med (Lausanne)"},{"key":"4583_CR13","unstructured":"VAsopressin LOading for Refractory septic shock VALOR study. https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000050288."},{"key":"4583_CR14","doi-asserted-by":"publisher","first-page":"100956","DOI":"10.1016\/j.eclinm.2021.100956","volume":"37","author":"S Rodr\u00edguez-Villar","year":"2021","unstructured":"Rodr\u00edguez-Villar S, Kraut JA, Ar\u00e9valo-Serrano J, et al. Systemic acidemia impairs cardiac function in critically Ill patients. EClinicalMedicine. 2021;37:100956. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100956.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"4583_CR15","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1213\/ANE.0b013e31822773ec","volume":"113","author":"RH Thiele","year":"2011","unstructured":"Thiele RH, Durieux ME. Arterial waveform analysis for the anesthesiologist: past, present, and future concepts. Anesth Analg. 2011;113(4):766\u201376. https:\/\/doi.org\/10.1213\/ANE.0b013e31822773ec.","journal-title":"Anesth Analg"},{"key":"4583_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1152\/ajplegacy.1963.205.1.30","volume":"205","author":"AG Wallace","year":"1963","unstructured":"Wallace AG, Skinner NS, Mitchell JH. Hemodynamic determinants of the maximal rate of rise of left ventricular pressure. Am J Physiol. 1963;205:30\u20136. https:\/\/doi.org\/10.1152\/ajplegacy.1963.205.1.30.","journal-title":"Am J Physiol"},{"issue":"2","key":"4583_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15441\/ceem.15.010","volume":"2","author":"S Weingart","year":"2015","unstructured":"Weingart S. Push-dose pressors for immediate blood pressure control. Clin Exp Emerg Med. 2015;2(2):131\u20132. https:\/\/doi.org\/10.15441\/ceem.15.010.","journal-title":"Clin Exp Emerg Med"},{"issue":"6","key":"4583_CR18","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1152\/jappl.2000.89.6.2268","volume":"89","author":"J Zhang","year":"2000","unstructured":"Zhang J, Lipa JE, Black CE, et al. Pharmacological characterization of vasomotor activity of human musculocutaneous perforator artery and vein. J Appl Physiol (1985). 2000;89(6):2268\u201375. https:\/\/doi.org\/10.1152\/jappl.2000.89.6.2268.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"4583_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","volume":"35","author":"LK Barrett","year":"2007","unstructured":"Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35(1):33\u201340. https:\/\/doi.org\/10.1097\/01.CCM.0000251127.45385.CD.","journal-title":"Crit Care Med"},{"issue":"6","key":"4583_CR20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/bja\/aei259","volume":"95","author":"H Beloeil","year":"2005","unstructured":"Beloeil H, Mazoit JX, Benhamou D, Duranteau J. Norepinephrine kinetics and dynamics in septic shock and trauma patients. Br J Anaesth. 2005;95(6):782\u20138. https:\/\/doi.org\/10.1093\/bja\/aei259.","journal-title":"Br J Anaesth"},{"issue":"6","key":"4583_CR21","first-page":"307","volume":"16","author":"G Nilsson","year":"1990","unstructured":"Nilsson G, Lindblom P, Ohlin M, Berling R, Vernersson E. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res. 1990;16(6):307\u201314.","journal-title":"Drugs Exp Clin Res"},{"issue":"4","key":"4583_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/bja\/aen017","volume":"100","author":"A Morelli","year":"2008","unstructured":"Morelli A, Ertmer C, Lange M, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008;100(4):494\u2013503. https:\/\/doi.org\/10.1093\/bja\/aen017.","journal-title":"Br J Anaesth"},{"issue":"6","key":"4583_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00134-011-2148-x","volume":"37","author":"A Morelli","year":"2011","unstructured":"Morelli A, Donati A, Ertmer C, et al. Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock. Intensive Care Med. 2011;37(6):963\u20139. https:\/\/doi.org\/10.1007\/s00134-011-2148-x.","journal-title":"Intensive Care Med"},{"key":"4583_CR24","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1007\/s001340000751","volume":"27","author":"DC Bracco","year":"2001","unstructured":"Bracco DC, Revelly JP. Systemic and splanchnic haemodynamic effects of vasopressin administration in vasodilatory shock. Intensive Care Med. 2001;27:S138.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4583_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1378\/chest.120.3.989","volume":"120","author":"CL Holmes","year":"2001","unstructured":"Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120(3):989\u20131002. https:\/\/doi.org\/10.1378\/chest.120.3.989.","journal-title":"Chest"},{"issue":"5","key":"4583_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.cir.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122\u20135. https:\/\/doi.org\/10.1161\/01.cir.95.5.1122.","journal-title":"Circulation"},{"issue":"10","key":"4583_CR27","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1210\/endo.138.10.5432","volume":"138","author":"M Thibonnier","year":"1997","unstructured":"Thibonnier M, Preston JA, Dulin N, Wilkins PL, Berti-Mattera LN, Mattera R. The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. Endocrinology. 1997;138(10):4109\u201322. https:\/\/doi.org\/10.1210\/endo.138.10.5432.","journal-title":"Endocrinology"},{"issue":"2 Pt 2","key":"4583_CR28","doi-asserted-by":"publisher","first-page":"F274","DOI":"10.1152\/ajprenal.1989.256.2.F274","volume":"256","author":"RM Edwards","year":"1989","unstructured":"Edwards RM, Trizna W, Kinter LB. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol. 1989;256(2 Pt 2):F274\u20138. https:\/\/doi.org\/10.1152\/ajprenal.1989.256.2.F274.","journal-title":"Am J Physiol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04583-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T12:15:01Z","timestamp":1700482501000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04583-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4583"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04583-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical study was approved by the Ethics Board of Hitachi General hospital (2020-130). We received informed consent from participants or their proxies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no competing interests related to this manuscript or the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}